A large scale study of angiotensin II inhibition therapy in an elderly population: the CHANCE study
| Autor: | Rol, Asmar, Sophie Nisse-Durgeat |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2006 |
| Předmět: | |
| Zdroj: | Vascular Health and Risk Management, Vol Volume 2, Pp 317-323 (2006) |
| Druh dokumentu: | article |
| ISSN: | 1178-2048 |
| Popis: | Roland Asmar1, Sophie Nisse-Durgeat21The Cardiovascular Institute, Paris, France; 2Laboratoire Takeda, Puteaux, FranceAbstract: This 8-week, multicenter study evaluated the efficacy and safety of candesartan cilexetil (CC, 8–16 mg) in elderly (>65 years) hypertensive patients. Patients (n=3013) received CC 8 mg during 8 weeks which eventually doubled to CC 16 mg at week 4 if blood pressure remained uncontrolled (>140/90 mmHg). At week 8, 65.5% of patients were normalized (BP |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|